[Federal Register Volume 71, Number 34 (Tuesday, February 21, 2006)]
[Notices]
[Page 8863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-2360]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Device for Cell 
Culturing, Monitoring and Containment

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), 
Department of Health and Human Services, is contemplating the grant of 
an exclusive worldwide license to practice the invention embodied in: 
E-171-2002, ``Cell Culturing and Storage Systems, Devices and Methods'' 
U.S. Patent Application 10/334,565 filed December 30, 2002; European 
Patent Application 03808601.3; rights are also pending in Canada and 
Australia; to KW Company, LLC, a New York company having its 
headquarters in Woodstock, New York. The United States of America is 
the assignee of the patent rights of the above invention. The 
contemplated exclusive license may be granted in the field of sales of 
devices for cell culturing, monitoring and containment.

DATES: Only written comments and/or applications for a license received 
by the NIH Office of Technology Transfer on or before April 24, 2006 
will be considered.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments and other materials relating to the contemplated license 
should be directed to: Michael A. Shmilovich, Esq., Office of 
Technology Transfer, National Institutes of Health, 6011 Executive 
Boulevard, Suite 325, Rockville, MD 20852-3804; Telephone: (301) 435-
5019; Facsimile: (301) 402-0220; E-mail: [email protected]. A 
signed confidentiality nondisclosure agreement will be required to 
receive copies of the patent applications.

SUPPLEMENTARY INFORMATION: The patent applications intended for 
licensure disclose and/or cover the following:

E-171-2002/0, ``Cell Culturing and Storage Systems, Devices and 
Methods;''

    The invention pertains to a closed chamber that provides an 
environment for long-term culture of cells such as stems cells of 
central nervous system (CNS) origin, embryonic stem cells, and other 
cells. The chamber is designed with top and bottom mounted cover slips 
that permit the observation of cells in culture under an optical 
microscope. This chamber has the ability to control volume and pressure 
of liquids and gases by an inlet tube and outlet tubes at two different 
vertical positions. The chamber also includes a ball joint assembly 
that allows for the manipulation of a glass microcapillary/
microelectrode to come in close contact with the developing cells. This 
microcapillary/microelectrode assembly can be used to either administer 
growth factors (e.g., monitoring growth factor levels such as BMP and 
CNTF) and also for electrical recording from the cells.
    The prospective exclusive license will be royalty bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. 
The prospective exclusive license may be granted unless, within sixty 
(60) days from the date of this published notice, NIH receives written 
evidence and argument that establishes that the grant of the license 
would not be consistent with the requirements of 35 U.S.C. 209 and 37 
CFR 404.7.
    Properly filed competing applications for a license filed in 
response to this notice will be treated as objections to the 
contemplated license. Comments and objections submitted in response to 
this notice will not be made available for public inspection, and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act, 5 U.S.C. 552.

    Dated: February 10, 2006.
Steven M. Ferguson,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer.
[FR Doc. E6-2360 Filed 2-17-06; 8:45 am]
BILLING CODE 4140-01-P